AiM COVID for Covid 19 Tracking and Prediction

University of Warwick (Coventry, UK) and NTUU "Igor Sikorsky" Kyiv Polytechnic Institute (Kyiv, Ukraine), together with ClickMedix LLC, have developed an app and a chatbot "AiM COVID" for efficient monitoring and mitigation of COVID-19. These products are available for free download on computers and mobile phones. These can be used by a wide range of users from various sectors - patients and people living with them, doctors, nurses, specialists, community health workers, hospitals, clinics, hospital IT staff, MHFA, and insurance companies.

Study Overview

• Status: Completed
• Conditions: COVID 19
• Intervention / Treatment: Other: No Intervention

• Study Type: Observational
• Enrollment (Actual): 80

Contacts and Locations

Study Locations

• United Kingdom
  • Leicester, United Kingdom
    • Aarogyam (UK)

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Participants who registered or used any community support services in Leicester

Description

Inclusion Criteria:

• Participants 18 and above
• living in UK
• reported with or without symptoms from February 28 to March 28 with community support groups

Exclusion Criteria:

• below 18 years old

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Physical symptoms	Self reported physical symptoms	1day
Contact History	Contact with suspected, confirmed or ill person	14 days
Travel History	Travel to or from overseas	14 days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Fever	Self reported body temperature	1 day
Headache	Self reported headache using yes/no	1 day
Soar Throat	Self reported soar throat using yes/no	1 day
Runny nose	Self reported runny nose using yes/no	1 day
Cough	Self reported cough using yes/no	1 day
Shortness of breath	Self reported shortness of breath symptoms using yes/no	1 day
Nausea	Self reported nausea using yes/no	1 day
Vomiting	Self reported vomiting using yes/no	1 day
Muscle pain	Self reported muscle pain using yes/no	1 day
Joint pain	Self reported joint pain using yes/no	1 day
Diarrhoea	Self reported Diarrhoea using yes/no	1 day
Other	Self reported other symptoms using yes/no	1 day
Hospitalisation history	Self reported hospitalisation using yes/no	1 day
Co-morbid conditions	Self reported co-morbid conditions using checked box	1 day

Collaborators and Investigators

• Sponsor: Aarogyam UK
• Collaborators: University of Warwick; Igor Sikorsky Kyiv Polytechnic Institute; ClickMedix LLC

Study record dates

Study Major Dates

• Study Start (ACTUAL): March 28, 2020
• Primary Completion (ACTUAL): April 14, 2020
• Study Completion (ACTUAL): April 17, 2020

Study Registration Dates

• First Submitted: April 17, 2020
• First Submitted That Met QC Criteria: April 17, 2020
• First Posted (ACTUAL): April 21, 2020

Study Record Updates

• Last Update Posted (ACTUAL): April 21, 2020
• Last Update Submitted That Met QC Criteria: April 17, 2020
• Last Verified: April 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; COVID-19
• Other Study ID Numbers: AU12

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No